Global Decentralized Clinical Trials Market is set to witness a healthy growth rate of 10% to reach $14.2 billion by 2026
Decentralized clinical trials (DCTs) employ a method of conducting clinical trials where parts or all of the trial happen outside a traditional physical clinic or trial site. Clinical trial studies are conducted via telemedicine, mobile/local healthcare providers & digital/mobile technologies. Covid-19 Pandemic spurs Adoption of Decentralized Clinical Trials Market Covid-19 has adversely impacted health services internationally and the clinical industry was no different. More than 2000 trials registered on ClinicalTrials.gov were terminated because of the challenges of doing clinical research during the Covid-19 pandemic. Covid-19 adversely impacted participant recruitment, retention, the safety of trial subjects, protocol compliance, and highlighted the need for safe, reliable, and secure remote capabilities, which in turn led to a renewed focus on digitization. In the wake of the Covid-19 pandemic, decentralized clinical trials (DCT) emerged as an important tool using which...